National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
Ro 50-3821

 A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called methoxypolyethylene glycol epoetin beta.

Previous Definitions:rituximab, RK-0202, RMP-7, RNA, Ro 31-7453
Next Definitions:rofecoxib, Roman chamomile, romidepsin, romiplostim, ropivacaine